Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
This facilitates weight maintenance and liver function improvement
Growth hormone release during deep sleep compounds peptide-driven repair
Company Home Products Blog Peptide Keyword Index About Contact Products All Products COA Support Email [email protected] [Monday to Friday : 8 AM 6 PM] Email
High Purity and Quality: Manufactured under stringent conditions for consistency and efficacy
US$ 24.49
US$ 23.78
US$ 28.82
US$ 24.45
US$ 27.95
US$ 20.23
US$ 27.63
US$ 27.67
US$ 26.94
US$ 26.61
US$ 23.34
